CN105056160A - Medicine composition for treating agalactia of cows and preparation method thereof - Google Patents
Medicine composition for treating agalactia of cows and preparation method thereof Download PDFInfo
- Publication number
- CN105056160A CN105056160A CN201510616083.1A CN201510616083A CN105056160A CN 105056160 A CN105056160 A CN 105056160A CN 201510616083 A CN201510616083 A CN 201510616083A CN 105056160 A CN105056160 A CN 105056160A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- rhizoma
- powder
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 229940079593 drug Drugs 0.000 title claims description 15
- 241000283690 Bos taurus Species 0.000 title abstract description 53
- 230000037006 agalactosis Effects 0.000 title abstract description 6
- 241000222336 Ganoderma Species 0.000 claims abstract description 28
- 239000000463 material Substances 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 20
- 210000003899 penis Anatomy 0.000 claims abstract description 19
- 210000001550 testis Anatomy 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- 239000000843 powder Substances 0.000 claims description 55
- 239000008194 pharmaceutical composition Substances 0.000 claims description 44
- 239000002245 particle Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000011812 mixed powder Substances 0.000 claims description 28
- 208000019395 Lactation disease Diseases 0.000 claims description 27
- 206010042576 Suppressed lactation Diseases 0.000 claims description 27
- 239000000706 filtrate Substances 0.000 claims description 24
- 241000124079 Mylabris Species 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 20
- 241000757701 Cyananthus Species 0.000 claims description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 19
- 241000722118 Thlaspi Species 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 8
- 239000013521 mastic Substances 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 6
- 230000000274 adsorptive effect Effects 0.000 claims description 4
- 238000005262 decarbonization Methods 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 239000012982 microporous membrane Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000008215 water for injection Substances 0.000 claims description 4
- 210000000952 spleen Anatomy 0.000 abstract description 54
- 210000004369 blood Anatomy 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 28
- 210000000481 breast Anatomy 0.000 abstract description 16
- 230000001105 regulatory effect Effects 0.000 abstract description 13
- 210000002445 nipple Anatomy 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 9
- 235000013336 milk Nutrition 0.000 abstract description 9
- 239000008267 milk Substances 0.000 abstract description 9
- 210000004080 milk Anatomy 0.000 abstract description 9
- 238000012360 testing method Methods 0.000 abstract description 8
- 210000005075 mammary gland Anatomy 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 4
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000056139 Brassica cretica Species 0.000 abstract 1
- 235000003351 Brassica cretica Nutrition 0.000 abstract 1
- 235000003343 Brassica rupestris Nutrition 0.000 abstract 1
- 241001635617 Canscora Species 0.000 abstract 1
- 240000000467 Carum carvi Species 0.000 abstract 1
- 235000005747 Carum carvi Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000037488 Coccoloba pubescens Species 0.000 abstract 1
- 235000014266 Geum aleppicum Nutrition 0.000 abstract 1
- 241000123870 Geum aleppicum Species 0.000 abstract 1
- 241001556624 Gonostegia Species 0.000 abstract 1
- 241000608174 Gymnadenia Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 241000756137 Hemerocallis Species 0.000 abstract 1
- 235000005769 Japanese ginseng Nutrition 0.000 abstract 1
- 241000201282 Limonium Species 0.000 abstract 1
- 241000623906 Lytta vesicatoria Species 0.000 abstract 1
- 241000168720 Panax japonicus Species 0.000 abstract 1
- 235000003174 Panax japonicus Nutrition 0.000 abstract 1
- 241000283150 Phoca vitulina Species 0.000 abstract 1
- 244000061632 Prinsepia uniflora Species 0.000 abstract 1
- 235000008997 Prinsepia uniflora Nutrition 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 240000001866 Vernicia fordii Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000010460 mustard Nutrition 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 description 32
- 210000003734 kidney Anatomy 0.000 description 30
- 241000411851 herbal medicine Species 0.000 description 26
- 208000002193 Pain Diseases 0.000 description 23
- 230000036407 pain Effects 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 20
- 206010011224 Cough Diseases 0.000 description 18
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 16
- 206010012735 Diarrhoea Diseases 0.000 description 14
- 206010030113 Oedema Diseases 0.000 description 14
- 230000036528 appetite Effects 0.000 description 13
- 235000019789 appetite Nutrition 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 206010003549 asthenia Diseases 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 230000006651 lactation Effects 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 230000008736 traumatic injury Effects 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 230000002354 daily effect Effects 0.000 description 7
- 230000037406 food intake Effects 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 208000010228 Erectile Dysfunction Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 208000007443 Neurasthenia Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000007096 poisonous effect Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010023644 Lacrimation increased Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000004317 lacrimation Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000590428 Panacea Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 241000410367 Clerodendrum thomsoniae Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000029836 Inguinal Hernia Diseases 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010026889 Mastitis postpartum Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000020264 Puerperal Infection Diseases 0.000 description 1
- 206010037294 Puerperal pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000775848 Syringa oblata Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 206010013864 duodenitis Diseases 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- UYXAWHWODHRRMR-UHFFFAOYSA-N hexobarbital Chemical compound O=C1N(C)C(=O)NC(=O)C1(C)C1=CCCCC1 UYXAWHWODHRRMR-UHFFFAOYSA-N 0.000 description 1
- 229960002456 hexobarbital Drugs 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000017376 neurovascular disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 239000010681 turmeric oil Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000009530 yishen Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine composition for treating agalactia of cows and a preparation method thereof. The medicine composition comprises the following raw medicinal materials: radix astragali, largehead atractylodes rhizome, rhizome of conic gymnadenia, root or all-grass of Aleppo avens, dried tangerine peel, manyprickle acathopanax root, lucid ganoderma, gynostemma pentaphyllum, fruit of caraway, Chinese date, heterophylly falsestarwort root, root of foldleaf daylily, hedge prinsepia nut, herb of Siberian sealavender, rhizoma dioscoreae, testes and penis of harbour seal, herb of common canscora, rhizome of largeleaf Japanese ginseng, root of tungoiltree, zedoray rhizome, seed of dish mustard, large blister beetle, all-grass of hirsute gonostegia and argent bluebellflower. The medicine composition has the beneficial effects that the medicine composition has the functions of tonifying the spleen and regulating qi and replenishing qi and nourishing blood, can also achieve the effects of promoting plumpness of breasts, normal development of nipples and fullness of milk, improving the immunities of cows and well ensuring normal growth of mammary glands and other body organs of the cows and has the advantages of high cure rate, quick effect, short course of treatment, no toxic or side effect, and the like.
Description
Technical field
The present invention relates to field of veterinary, particularly a kind ofly treat pharmaceutical composition of milch cow hypogalactia and preparation method thereof.
Background technology
Cattle farm often occur young cattle arrive mating age still non-estrus, become milch cow long-term non-estrus in puerperal, the phenomenon such as output falls sharply, therefore some cattle eliminates and causes no small loss.Female animal is young, development of breast imperfection and lack milk.Show as breast tightly little, nipple cripetura, outward appearance is inmature, agalactosis, refusal suckling.Cow hypogalactia after delivery is due to nutritional disorder, the thin deficiency of vital energy of body, or body to strengthen waist good, or puerperal half empty half heat, or the common disease that many reasons causes after the recovery from illness of puerperal infection disease etc.
The main cause of general cow hypogalactia after delivery has: 1. feeding and management is not good at or the rotten feedstuff that goes rotten of feeding causes milch cow to become thin; 2. severe cold or hot overstimulation; 3. mammary gland dysplasia or body of gland disorder; 4. old or excessive forced labour, causes mammary gland hypofunction or stopping; 5. earlier mating premature labor, puerperal fever or mastitis; 6. galactopoiesis milch cow duration drylot feeding material causes hypomotility or Other diseases etc.Be subject to the impact of certain factor during breast and cause mammary gland disorder, causing lactation amount to reduce or agalactia.Be mainly in malnutrition, old-age group and first milking cow clinically.The cause of disease: malnutrition is the main cause causing milch cow hypogalactia.As hot summer high temperature season milch cow appetite die-offs or do not eat, Winter-Spring milch cow latter half of gestation drylot feeding lacks greenfeed and high-quality Radix Glycyrrhizae, concentrate undersupply etc. all can cause cow hypogalactia after delivery.
At present, western medical treatment milch cow hypogalactia widely applies antibiotic, the chemical synthetic drugs such as Pituamin.Western medicine is for motherland's Chinese medicine, and the medicine that doctor trained in Western medicine is used, generally makes with chemical synthesis process or obtain through refining from natural product and form.The course for the treatment of is longer, and drug residue is comparatively large, and effect is undesirable, has impact to a certain degree to the health of milch cow and consumer.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of pharmaceutical composition for the treatment of milch cow hypogalactia, the various defects of Chinese medicine of the prior art and Western medicine can be overcome, pharmaceutical composition of the present invention has spleen invigorating and regulates the flow of vital energy, effect of benefiting qi and nourishing blood, full and the nipple normal development of breast can also be promoted, milk is full, improve the immunity of milch cow, but also can be good at the normal growth ensureing cow mammary gland and other organs of health thereof, there is cure rate high, instant effect, treatment short treating period, the advantage such as have no side effect.
In order to realize foregoing invention object, the invention provides a kind of pharmaceutical composition for the treatment of milch cow hypogalactia, described pharmaceutical composition comprises following raw medicinal material: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Gymnadeniae, Radix seu Herba Gei aleppici, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae, Herba Limonii Gmelinii, Rhizoma Dioscoreae, Testis et penis callorhini, Herba Canscorae, Rhizoma panacis majoris, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae and Cyananthus argernteus marg..
In described pharmaceutical composition, the ratio of weight and number of each raw medicinal material is: Radix Astragali 10-25 weight portion, Rhizoma Atractylodis Macrocephalae 12-35 weight portion, Rhizoma Gymnadeniae 10-22 weight portion, Radix seu Herba Gei aleppici 13-27 weight portion, Pericarpium Citri Reticulatae 10-30 weight portion, Radix Et Caulis Acanthopanacis Senticosi 10-32 weight portion, Ganoderma 15-35 weight portion, Herb Gynostemmae Pentaphylli 14-36 weight portion, Fructus cari carvi 13-31 weight portion, Fructus Jujubae 10-35 weight portion, Radix Pseudostellariae 13-34 weight portion, Radix hemerocalis plicatae 3-5 weight portion, Nux Prinsepiae 12-22 weight portion, Herba Limonii Gmelinii 13-33 weight portion, Rhizoma Dioscoreae 12-32 weight portion, Testis et penis callorhini 12-36 weight portion, Herba Canscorae 10-21 weight portion, Rhizoma panacis majoris 12-25 weight portion, Radix Aleuritis Fordii 3-5 weight portion, Rhizoma Curcumae 11-31 weight portion, Semen thlaspis 13-32 weight portion, Mylabris 10-30 weight portion, Herba Gonostegiae hirtae 13-36 weight portion and Cyananthus argernteus marg. 14-24 weight portion.
In described pharmaceutical composition, the ratio of weight and number of each raw medicinal material is: the Radix Astragali 20 weight portion, the Rhizoma Atractylodis Macrocephalae 32 weight portion, Rhizoma Gymnadeniae 15 weight portion, Radix seu Herba Gei aleppici 25 weight portion, Pericarpium Citri Reticulatae 28 weight portion, Radix Et Caulis Acanthopanacis Senticosi 25 weight portion, Ganoderma 30 weight portion, Herb Gynostemmae Pentaphylli 35 weight portion, Fructus cari carvi 23 weight portion, Fructus Jujubae 35 weight portion, Radix Pseudostellariae 33 weight portion, Radix hemerocalis plicatae 3 weight portion, Nux Prinsepiae 22 weight portion, Herba Limonii Gmelinii 30 weight portion, Rhizoma Dioscoreae 25 weight portion, Testis et penis callorhini 36 weight portion, Herba Canscorae 20 weight portion, Rhizoma panacis majoris 22 weight portion, Radix Aleuritis Fordii 3 weight portion, Rhizoma Curcumae 31 weight portion, Semen thlaspis 32 weight portion, Mylabris 20 weight portion, Herba Gonostegiae hirtae 36 weight portion and Cyananthus argernteus marg. 14 weight portion.
Described pharmaceutical composition also comprises Radix Et Rhizoma Nardostachyos, Poria cum Radix Pini, Flos Loropetali (Herba Loropetali), Rhizoma Alismatis, Poria and the Rhizoma Anemarrhenae.
In described pharmaceutical composition, the parts by weight of each raw medicinal material are: Radix Astragali 10-25 weight portion, Rhizoma Atractylodis Macrocephalae 12-35 weight portion, Rhizoma Gymnadeniae 10-22 weight portion, Radix seu Herba Gei aleppici 13-27 weight portion, Pericarpium Citri Reticulatae 10-30 weight portion, Radix Et Caulis Acanthopanacis Senticosi 10-32 weight portion, Ganoderma 15-35 weight portion, Herb Gynostemmae Pentaphylli 14-36 weight portion, Fructus cari carvi 13-31 weight portion, Fructus Jujubae 10-35 weight portion, Radix Pseudostellariae 13-34 weight portion, Radix hemerocalis plicatae 3-5 weight portion, Nux Prinsepiae 12-22 weight portion, Herba Limonii Gmelinii 13-33 weight portion, Rhizoma Dioscoreae 12-32 weight portion, Testis et penis callorhini 12-36 weight portion, Herba Canscorae 10-21 weight portion, Rhizoma panacis majoris 12-25 weight portion, Radix Aleuritis Fordii 3-5 weight portion, Rhizoma Curcumae 11-31 weight portion, Semen thlaspis 13-32 weight portion, Mylabris 10-30 weight portion, Herba Gonostegiae hirtae 13-36 weight portion, Cyananthus argernteus marg. 14-24 weight portion, Radix Et Rhizoma Nardostachyos 10-20 weight portion, Poria cum Radix Pini 10-30 weight portion, Flos Loropetali (Herba Loropetali) 12-32 weight portion, Rhizoma Alismatis 11-21 weight portion, Poria 12-32 weight portion and Rhizoma Anemarrhenae 14-24 weight portion.
In described pharmaceutical composition, the parts by weight of each raw medicinal material are: the Radix Astragali 20 weight portion, the Rhizoma Atractylodis Macrocephalae 32 weight portion, Rhizoma Gymnadeniae 15 weight portion, Radix seu Herba Gei aleppici 25 weight portion, Pericarpium Citri Reticulatae 28 weight portion, Radix Et Caulis Acanthopanacis Senticosi 25 weight portion, Ganoderma 30 weight portion, Herb Gynostemmae Pentaphylli 35 weight portion, Fructus cari carvi 23 weight portion, Fructus Jujubae 35 weight portion, Radix Pseudostellariae 33 weight portion, Radix hemerocalis plicatae 3 weight portion, Nux Prinsepiae 22 weight portion, Herba Limonii Gmelinii 30 weight portion, Rhizoma Dioscoreae 25 weight portion, Testis et penis callorhini 36 weight portion, Herba Canscorae 20 weight portion, Rhizoma panacis majoris 22 weight portion, Radix Aleuritis Fordii 3 weight portion, Rhizoma Curcumae 31 weight portion, Semen thlaspis 32 weight portion, Mylabris 20 weight portion, Herba Gonostegiae hirtae 36 weight portion, Cyananthus argernteus marg. 14 weight portion, Radix Et Rhizoma Nardostachyos 20 weight portion, Poria cum Radix Pini 25 weight portion, Flos Loropetali (Herba Loropetali) 32 weight portion, Rhizoma Alismatis 21 weight portion, Poria 30 weight portion and the Rhizoma Anemarrhenae 22 weight portion.
The dosage form of described pharmaceutical composition is injectable powder, and its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
The dosage form of described pharmaceutical composition is powder, and its preparation method comprises the following steps:
The first step, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae and Herba Limonii Gmelinii are mixed in described ratio, with being the dissolve with ethanol of 85% ~ 95% relative to the determining alcohol of 3 ~ 5 times of mixture quality obtained, reflux was extracted after 2 ~ 4 hours, filter, obtain the first filtrate; By filtering residue again with the dissolve with ethanol of the determining alcohol 85% ~ 95% of 1 ~ 2 times relative to the mixture quality obtained, reflux was extracted after 1 ~ 2 hour, filtered, obtained the second filtrate; Merge the first filtrate and the second filtrate, decompression recycling ethanol to be concentrated into liquor strength be 0.7 ~ 0.9g crude drug/mL, through the macroporous adsorptive resins eluting that volume is 5L, first use deionized water or the distilled water eluting of 5 times of resin column volumes, be 90% ~ 95% ethanol elution with the determining alcohol of 3 times of resin column volumes again, collect ethanol elution, concentrating under reduced pressure removing ethanol, drying is also ground into powder;
Second step, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae and Cyananthus argernteus marg. are mixed in described ratio, add the ethanol of the determining alcohol 85% ~ 95% of 2 ~ 4 times relative to the mixture quality obtained, heating and refluxing extraction 1 ~ 2 time, extracting solution merges, with the centrifugal remove impurity of tube centrifuge, when the extracting solution after remove impurity being evaporated under the condition of 60 DEG C ~ 70 DEG C 60 DEG C, relative density is the mastic of 1.20 ~ 1.23, and the mastic spray dryer after concentrated is dried to powder;
3rd step, mixes surplus stock medical material in described ratio, adds the water dissolution of 2 ~ 4 times relative to the mixture quality obtained, and heating decoction 2 ~ 4 hours, filters; By filtering residue again with the water dissolution of 1 ~ 2 times relative to the mixture quality obtained, again heat decoction 1 ~ 2 hour, filter; Merge the filtrate of twice, concentrating under reduced pressure removing moisture, drying is also ground into powder;
4th step, the powder mixing first step, second step and the 3rd step obtained, is screened into 80 ~ 120 object fine powders subsequently, is dropped in mixing and blending machine by the fine powder of acquisition and stirs, namely obtain powder.
The invention has the beneficial effects as follows: pharmaceutical composition of the present invention has spleen invigorating and regulates the flow of vital energy, effect of benefiting qi and nourishing blood, full and the nipple normal development of breast can also be promoted, milk is full, improves the immunity of milch cow, but also can be good at the normal growth ensureing cow mammary gland and other organs of health thereof, there is cure rate high, instant effect, treatment short treating period, the advantage such as have no side effect.
Detailed description of the invention
Chinese veterinarian thinks, kidney essense, i.e. the kidney vital essence of hiding.It derives from congenital essence, and relying constantly supplementing nutrition of acquired essence, is the material base of renal function activity, is body vital movement basis, plays an important role to the various physiological activity of body.Kidney qi, the gas of kidney essense instituteization life, refers to the physiological function that kidney vital essence produces in fact.Gas is in Chinese medicine, and referring to the most base substance forming human body and maintain human life activity, is the material base of zang-fu differentiation functional activity.Gas has the attribute of motion, and the athletic performance of gas is the functional activity of human body zang-fu differentiation.Zang-fu differentiation is the aggregate concept of structure and fuction dialectical unity.The digestion of ingesta and the absorption of nutrient substance, to transfer, be the physiological activity that under multiple internal organs such as taste, liver and gall, intestine and small intestine participate in jointly one is complicated, wherein spleen plays a leading role: the transportation capabilities of spleen mainly rely on temper the lucid yang sending up and the warm effect of spleen sun: the normal function of the spleen tending to ascent." people Na Shuigu, temper and rise " (" three-character medical verses annex internal organs "), " spleen rises and kind mill " (" four holy heart sources "), water paddy enters stomach, entirely relies spleen sun transporting for it.Therefore " spleen has one/sun, and can disappear one/water paddy; Spleen has ten/sun, and can disappear ten/water paddy " (" curing former ").
Pharmaceutical composition of the present invention is regulated the flow of vital energy with spleen invigorating, the principle of benefiting qi and nourishing blood, provide a kind of pharmaceutical composition for the treatment of milch cow hypogalactia, comprise following raw medicinal material: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Gymnadeniae, Radix seu Herba Gei aleppici, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae, Herba Limonii Gmelinii, Rhizoma Dioscoreae, Testis et penis callorhini, Herba Canscorae, Rhizoma panacis majoris, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae, Cyananthus argernteus marg., Radix Et Rhizoma Nardostachyos, Poria cum Radix Pini, Flos Loropetali (Herba Loropetali), Rhizoma Alismatis, Poria and the Rhizoma Anemarrhenae.
The pharmacological property of above-mentioned each raw medicinal material is as follows:
Semen thlaspis: nature and flavor: pungent, tepor.1. " herbal classic ": " acrid in the mouth, tepor." 2. " not Lu ": " be nontoxic." cure mainly: control conjunctival congestion and swelling pain and shed tears.1. " herbal classic ": " eliminating impediment, tonifying five ZANG-organs, benefit is with nothing left for main improving eyesight, ophthalmalgia lacrimation." 2. " not Lu ": " treats trusted subordinate's lumbago." 3. " property of medicine opinion ": " treating the liver man gather, and eyes is red swollen."
Flos Loropetali (Herba Loropetali): nature and flavor: sweet in the mouth; Puckery; Property is put down.Gui Jing: and; Spleen; Large intestine channel.Cure mainly: clearing and antitussive; Astringing to arrest bleeding.Main cough due to lung-heat; Spitting of blood epistaxis; Have blood in stool; Dysentery; Have loose bowels; Metrorrhagia.
Poria cum Radix Pini: nature and flavor: sweet; Light; Property is put down.Gui Jing: the heart; Spleen channel.Cure mainly: mind calming; Calm the nerves; Diuretic.Main palpitation with fear; Forgetful; Forgetful insomnia; Infantile convulsion; Dysuria.
Cyananthus argernteus marg.: nature and flavor: sweet, bitter, temperature.Cure mainly: spleen invigorating dehumidifies, dredge the meridian passage.Cure mainly children's's breast poison (eating place milk) diarrhoea, rheumatalgia, traumatic injury.
Herba Gonostegiae hirtae: source: come from " Guizhou side's medicine among the people collection ".Nature and flavor: sweet; Micro-hardship; Cool in nature.Cure mainly: spleen invigorating removing food stagnancy; Inducing diuresis and reducing edema; Dissipating blood stasis stops blooding.Main acute mastitis; Toxic swelling; Dysentery; Dyspepsia; Abdominal pain due to retention of food; Glycoside amasss; Leukorrhagia; Edema; Dysuria; Dysmenorrhea; Traumatic injury; Hemoptysis; Spit blood; Traumatic hemorrhage.. " Traditional Chinese Medicine in Sichuan will " strengthening spleen, tonifying kidney.
Radix Aleuritis Fordii: source: " Traditional Chinese Medicine in Sichuan will ".Nature and flavor: pungent, cold, poisonous.1. " Traditional Chinese Medicine in Sichuan will ": " cold in nature, acrid in the mouth, slightly poisonous." 2. " Guizhou medical herbs ": " is cool in nature, acrid in the mouth." curing mainly: " Shaanxi Chinese herbal medicine ": " parasite killing, helps digestion and regulates the flow of vital energy, sharp expectorant.Control ascariasis, fullness and distention in the chest and hypochondrium, anorexia, asthma, scrofula."
Rhizoma Alismatis: nature and flavor: sweet, cold.Gui Jing: return kidney, urinary bladder channel.Cure mainly: diuresis, clearing away damp-heat.For dysuria, edema distension, oliguria of having loose bowels, dizziness due to fluid-retention, the puckery pain of pyretic stranguria; Hyperlipidemia.
Rhizoma panacis majoris: nature and flavor: bitter sweet, cold." Shaanxi Chinese herbal medicine ": " relieving convulsionly to relieve dizziness, high fever, infantile convulsions, epilepsy, etc., except rheumatism, stomach invigorating of regulating the flow of vital energy, pain relieving.Control infantile convulsion, rheumatic arthritis, stomachache, toxic swelling malignant boil."
Herba Canscorae: nature and flavor: 1. " Guangxi Chinese herbal medicine ": " the micro-sweet micro-hardship of taste, property is put down, nontoxic." 2. " the practical Chinese herbal medicine in Guangxi newly selects ": " mildly bitter flavor, cool in nature.Cure mainly: heat-clearing and toxic substances removing, promoting blood circulation and stopping pain.Control cough due to lung-heat, hepatitis, leptospirosis, jaundice, chest pain, stomachache, the stasis of blood in traumatic injury, venom.1. " Guangxi Chinese herbal medicine ": " regulate the flow of vital energy, pain relieving, cough-relieving.Control cough due to lung-heat, heart peratodynia, venom." 2. " the practical Chinese herbal medicine in Guangxi newly selects ": " cool liver and gall, promoting blood circulation and stopping pain.To harness the Yellow River subcutaneous ulcer, hepatitis, chest pain, stomachache, internal traumatic injury." 3. Guangzhou air force " conventional Chinese herbal medicine handbook ": " controls acute bronchitis, pneumonia, acute gastritis, duodenitis."
Herba Limonii Gmelinii: nature and flavor: bitter, salty, temperature.Cure mainly: invigorate blood circulation, hemostasis, warming middle-JIAO and strengthening the spleen, strengthening by means of tonics.For menoxenia, dysfunctional uterine hemorrhage, bleeding hemorrhoids, gastric ulcer, insufficiency of the spleen edema.
Radix hemerocalis plicatae: source: " Kunming conventional medical herbs among the people ".Nature and flavor: sweet are flat.1. " Kunming conventional medical herbs among the people ": " property is put down, sweet in the mouth.Slightly poisonous." 2. " choosing of Yunnan Chinese herbal medicine ": " Gan Weixin is flat." cure mainly: nourish blood suppressing the hyperactive liver, inducing diuresis to remove edema.Control dizziness, tinnitus, cardiopalmus, lumbago, spit blood, epistaxis, large intestine hematochezia, edema, gonorrhea, pharyngalgia, acute mastitis.1. " Kunming conventional medical herbs among the people ": " tonify deficiency is stimulated the secretion of milk, suppressing the hyperactive liver diuresis, detumescence hemostasis." 2. " choosing of Yunnan Chinese herbal medicine ": " is calm, diuresis, detumescence.Control giddy, cardiopalmus, dysuria, edema, urinary tract infection, galactopoiesis is not enough, arthralgia." 3. " Yunnan Chinese herbal medicine ": " nourish blood tonify deficiency, heat clearing away."
Fructus Jujubae: nature and flavor: sweet, temperature.Gui Jing: return spleen, stomach warp.Cure mainly: really (Fructus Jujubae): invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind.For insufficiency of the spleen lack of appetite, weak loose stool, woman hysteria.Bark: antiinflammatory, hemostasis, antidiarrheal.For tracheitis, enteritis, dysentery, metrorrhagia; Traumatic hemorrhage is controlled in external.Root: circulation of qi promoting, invigorates blood circulation, regulating menstruation.For menoxenia, redly to collapse, leucorrhea.
Radix Pseudostellariae: nature and flavor: sweet, micro-hardship is flat.Gui Jing: return spleen, lung meridian.Cure mainly: replenishing QI to invigorate the spleen, promoting the production of body fluid for nourishing the lung.Tired for insufficiency of the spleen body, inappetence, weak after being ill, deficiency of both vital energy and Yin, spontaneous perspiration is thirsty, dryness of the lung dry cough.
Fructus cari carvi: nature and flavor: 1. " Chinese herbal medicine is commonly used in Tibet ": " warm in nature, taste is micro-pungent." 2. " plateau Chinese herbal treatment handbook ": " is warm in nature, and sweet in the mouth is pungent." return through: " plateau Chinese herbal treatment handbook ": " enters kidney, stomach warp." curing mainly: 1. " Chinese herbal medicine is commonly used in Tibet ": " fragrant stomach invigorating, wind dispelling is regulated the flow of vital energy and is treated for stomachache, stomachache, inguinal hernia." 2. " plateau Chinese herbal treatment handbook ": " wind dispelling method is trembled with fear, spleen benefiting and stimulating the appetite.Control cold stagnant lumbago, cold syndrome of the stomach vomiting."
The Rhizoma Atractylodis Macrocephalae: nature and flavor: bitter, sweet, temperature.Gui Jing: return spleen, stomach warp.Cure mainly: invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.Rhizoma Atractylodis Macrocephalae spleen invigorating, stomach function regulating, antiabortive.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, frequent fetal movement.
Pericarpium Citri Reticulatae: nature and flavor: bitter, pungent, temperature.Gui Jing: return lung, spleen channel.Cure mainly: regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm.
The Radix Astragali: sweet, tepor; Return lung, spleen, liver, kidney channel.Air making-up and spleen enlivening, benefit defends real table, ascending up spleen-Qi and Yang, poison holding sore, inducing diuresis to remove edema.Essentials of Matea Medica: " Radix Astragali, life consolidating superficial resistance losslessly can be sent out, and have antiperspirant to stop; Process with invigorating middle warmer, beneficial vigour, strong taste.Hemopoietic, granulation promoting, evacuation of pus expelling the toxic substance from the body with tonic, carbuncle sore panacea.Variola does not rise, and yang deficiency should it without hot person." " book on Chinese herbal medicine justice ": " replenishing vital QI with drugs of warm nature taste, all middle gas is depressed, and spleen soil is weak, and the person of sinking is the most suitable for clearing heat in QI system for the Radix Astragali, soil in tonification.Its skin goes directly the skin table muscle of people, and solid protection defends sun, and enriching table point, is its speciality, so all diseases of exterior deficiency, and the most refreshing agent." function consolidating superficial resistance arresting sweating, inducing diuresis to remove edema, the evacuation of pus of holder skin ulcer, regulating fluid apssage.The Radix Astragali makes contractile ability strengthen, and can improve the blood circulation of whole body, can coronary artery dilator, Renal vascular and Rhizoma Bistortae peripheral vessel, make cutaneous circulation vigorous; The nonspecific immunity power of body can be improved, protect the liver and fall hypoglycemic effect, have inhibitory action to staphylococcus, blood dissolubility streptococcus, Diplococcus pneumoniae, dysentery bacterium etc.The Radix Astragali can appreciable impact splenocyte Information Conduction, realizes immunoregulation effect.Can be used for hypertension, ischemic heart desease, acute glomerulonephritis, gastric ulcer, psoriasis, diabetes, osteoporosis.
Rhizoma Gymnadeniae: the herb medicine being the nourishing of old people's life lengthening, for the ginseng kind that treasure hands down is planted by family, there is cultivation in a small amount various places.In 2 or three year autumn after plantation, excavate the Rhizoma Gymnadeniae tuber that (or pulling out) only has 1.5 to 2.5 centimetres of footpath width, remove stem and leaf and fibrous root, put into boiling water pot after cleaning and boil to without Bai Xinwei degree, dry for subsequent use after dragging for.Its nature and flavor are sweet, micro-hardship, cool, have the kidney invigorating and essence nourishing, effect of regulating QI to relieve pain.Rhizoma Gymnadeniae is illiteracy, Tibetan medicine, and also use among the people, the traditional Chinese medical science is used less.Sweet, the micro-hardship of meridian distribution of property and flavor, cool, be slightly cold.Sweet in the mouth, property is put down.(1) " the conventional Chinese herbal medicine handbook in the north ": " sweet in the mouth, micro-hardship, cold nature.(2) " Chinese herbal medicine handbook is commonly used in Liaoning ": " sweet, micro-hardship, tepor." (3) " Chinese herbal medicine is commonly used in Sichuan ": " sweet, flat.Enter lung, spleen, stomach warp." (4) " Chinese herbal medicine handbook is commonly used in Qinghai ": " and pungent, bitter, temperature." (5) " national Chinese herbal medicine compilation ": " and sweet, micro-hardship, cool." function cures mainly: the kidney invigorating and essence nourishing, weak after being ill, cough, leucorrhea, traumatic injury, congestion swells and ache.Relieving cough and asthma, Yishen Jianpi, regulates the flow of vital energy and blood, pain relieving.Cure mainly cough and asthma due to lung deficiency; Asthenia is become thin; Neurasthenia; Suffer from a deficiency of the kidney lassitude loin and legs; Sexual impotence; Spermatorrhea; Frequent micturition; Chronic hepatitis; Chronic diarrhea; Lose blood; Leukorrhagia; Breast is few; Traumatic injury.(1) " will planted by northeast medicine ": " make mucus, for poisoning and under rushing down; Steep in wine as strong, essence-replenishing preparation." (2) " Heilungkiang Chinese medicine among the people ": " steep in wine and control impotence." (3) " illustrated handbook planted by middle traditional Chinese medicines ": " repercussive.Control traumatic injury, hematocele is not all right." (4) " the conventional Chinese herbal medicine handbook in the north ": " the kidney invigorating benefit is empty, regulates the flow of vital energy and blood, promoting the circulation of blood.Control neurasthenia, chronic diarrhea, leucorrhea, chronic hemorrhage." (5) " Chinese herbal medicine handbook is commonly used in Heilungkiang ": " and take muscle reinforcing and bone strengthening for a long time, strong, essence by force, removing toxic substances.Control sexual neurasthenie, sexual impotence, YANG asthenia disease, and control enteritis, diarrhea." (6) " Chinese herbal medicine handbook is commonly used in northeast ": " supporing yang." (7) " Chinese herbal medicine is commonly used in Sichuan ": " blood yiqi, promoting the production of body fluid to quench thirst.Control cough and asthma due to lung deficiency, chronic consumptive disease weakness and emaciation, hypogalactia juice." (8) " Shaanxi Chinese herbal medicine ": " strengthening by means of tonics, spleen reinforcing lung moistening are calmed the nerves relieving convulsion, QI invigorating pain relieving.Control physical weakness, neurasthenia, impairment caused by overstrain, cough, asthma." (9) " Chinese herbal medicine is commonly used in Tibet ": " control chronic hepatitis." (10) " Chinese herbal medicine handbook is commonly used in Qinghai ": " warming the kidney to invigorate YANG.Control the lassitude loin and legs that suffers from a deficiency of the kidney unable, sexual impotence, spermatorrhea, frequent micturition." (11) " Shanxi Chinese medicinal herbal ": " pain relieving, hemostasis.Control trauma pain, spitting of blood, epistaxis, has blood in stool.”
Radix seu Herba Gei aleppici: analgesia, blood pressure lowering, regulating menstruation, expelling wind and removing dampness.For hypertension, dizziness headache, menoxenia, lower abdominal pain, leucorrhea, infantile convulsion, lumbago, skelalgia of rheumatism; Carbuncle furuncle and phyma poison is controlled in external, traumatic injury.
Radix Et Caulis Acanthopanacis Senticosi: acrid in the mouth, hardship, micro-sweet, warm in nature, enters spleen, kidney, heart channel, there is replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization, effect of expelling wind and removing dampness, soft for anemofrigid-damp arthralgia, lumbocrural pain, muscles and bones flaccidity, be slow in action, the card such as body weakness with emaciation is weak, traumatic injury, fracture, edema, beriberi, uncontrolled urination are itched.The sweet A of Radix Et Caulis Acanthopanacis Senticosi is carotene, also containing this constituents in people Ginseng.The excretion of cholesterol can be promoted in human body, the too high disease of blood cholesterol level can be prevented and treated.The sweet B of Radix Et Caulis Acanthopanacis Senticosi is Syringa oblata Lindl. element (Syringin), is the main strong composition of Radix Et Caulis Acanthopanacis Senticosi, has short gonad, radioprotective, fatigue-resisting function, has the physiologically active similar to Ren Ginseng Saponin.Radix Et Caulis Acanthopanacis Senticosi is containing super oxidation disproportionation ferment SOD (Superoxidedimutase) complex, SOD has good anti-oxidation function, the effect of human immunity and the attack of opposing free radical can be strengthened, there is antioxidation, body immunity can be strengthened, prevent aging and promotion health.
Ganoderma: the Ganoderma that Ganoderma makes medicine is Ganoderma lucidum (Leyss. Ex Fr.) Karst. and Ganoderma, and its property of medicine is sweet, flat.GUIXIN, liver, spleen, lung, the kidney Five Classics.Cure mainly asthenia, cough, asthma, insomnia, dyspepsia, malignant tumor etc.To human liver cancer cell, there is cytotoxicity, also can suppress the release of histamine, there is hepatoprotective effect and there is anti-allergic effects etc.No matter before liver injury occurs or after generation, taking Ganoderma all can the liver protecting, alleviates hepatic injury.Ganoderma can promote that liver is to the metabolism of medicine, poisonous substance, has definite curative effect for toxic hepatitis.Zoopery and clinical trial all show, Ganoderma can coronary artery dilator effectively, increases coronary flow; improve Myocardial Microcirculation, strengthen the supply of myocardium oxygen and energy, therefore; to myocardial ischemia, there is protective effect, treatment and the prevention of coronary heart diseases and angina pectoris etc. can be widely used in.Polysaccharide contained by Ganoderma, polypeptide etc. have obvious function of delaying senility.Extract energy exciting motion suppresses, mobility is reduced, coordination exercise is lacked of proper care, presents the sick effect in dose-dependent town, can curtail sleep to hexobarbital sleep effect, the time that central stimulants caffeine causes spasm and death can be extended, these results show, Ganoderma is inhibition effect to maincenter.
Herb Gynostemmae Pentaphylli: sweet in the mouth, hardship, cold nature; Return lung meridian, spleen channel, kidney channel.Energy QI invigorating, calms the nerves, blood pressure lowering, heat-clearing and toxic substances removing, eliminating phlegm and stopping cough.After small number of patients is taken medicine, there is the symptom such as nausea and vomiting, abdominal distention diarrhoea (or constipation), dizziness, dim eyesight, tinnitus.After taking Herb Gynostemmae Pentaphylli, enterogastric peristalsis is accelerated, and it is long that appetite increases the resistance to time of hungering and thirst, and not only treats constipation but also control loose stool.Reaction that is excited to cerebral cortex and that suppress can keep suitable balance, has dual regulation to nervus centralis.There is excellent analgesia, sleeping, antitonic effect.In reduction myocardial wall anxiety, relax on the basis of cerebrovascular and peripheral vascular resistance, heart and brain vigor can be strengthened, strengthen coronary flow, relax arteriosclerosis, impel entirety to circulate more vigorous and smooth.Experiment proves, and the not rich Herb Gynostemmae Pentaphylli group that takes of diet, and and avoid meat and refuses to obey Herb Gynostemmae Pentaphylli group, make regular check on and compare, body inner bag is consolidated close with neutral fat content.Herb Gynostemmae Pentaphylli has benign transformed regulating action to body fat mass in human body as can be seen here.
Nux Prinsepiae: sweet, is slightly cold.Return Liver Channel.Nourishing the liver to improve visual acuity, wind-dispelling heat-dissipating.For conjunctival congestion and swelling pain, red and fester on the palpebral margin, the dark photophobia of order.1. " not Lu ": " be slightly cold, nontoxic." 2. " medical center bun is wanted ": " sweet salty, cold." enter liver, heart channel.1. " Thunder God concocts property of medicine solution ": " enter the heart, liver, spleen three warp." pathogenic wind expelling heat radiation, beneficial aquatic light.Three through all blood is also dirty, and blood obtains it and supports, then order disease is put down.All order diseases, at table, are worked as wind and heat dispersing, are suffered from a deficiency of the kidney at inner genus, insufficiency of blood, refreshing labor, should calm the nerves by kidney-replenishing blood-nourishing.Hypermetropia is that kidney water loses, and myopia is that fire is not enough.2. " jade seizes medicine solution ": " start with lunar lung, liver channel of foot-Jueyin." effect: dispel the wind, heat radiation, nourishing the liver, improving eyesight.Control conjunctival congestion and swelling pain, dim shy the moon, the rotten many tear of the corner of the eyes, epistaxis.Also trusted subordinate's pathogenic heat are controlled, stagnation of QI fullness and oppression sensation in the epigastrium due to accumulation of phlegm.Moderns are only with treating eye.(CHEN Zang-Qi is said) raw foot of controlling is slept, and ripely controls sleeplessness." medical center bun want ": white Nux Prinsepiae, the same Semen Ziziphi Spinosae of achievement, raw then salty many, the use of spreading gods; Ripe then sweet many, the master of stable gods.Enter to know that it controls order disease, and do not know that its energy reinforcing the heart is of a specified duration.2, " herbal classic ": main trusted subordinate's pathogens agglomerating gas, improving eyesight, conjunctival congestion with ophthalmalgia hinders lacrimation.3, " WU Pu Bencao ": the strong will of invigorating middle warmer, improve visual and auditory acuity.4, " not Lu ": the order corner of the eyes that swells is rotten, to fullness and oppression sensation in the epigastrium due to accumulation of phlegm gas under the broken heart.5, " property of medicine opinion ": control epistaxis.6, supplement to the Herbal: raw foot of controlling is slept, ripely controls sleeplessness.7, " book on Chinese herbal medicine covers bamboo fish trap ": specially control ophthalmology, disappear the rotten string of upper lower eyelid swelling due to wind, except left and right corner of the eyes thermal boundary bulbar conjunctiva polyp, annealing arresting lacrimation, beneficial aquatic light.
Rhizoma Dioscoreae: sweet, flat, enters spleen, lung, kidney channel.Spleen benefiting and stimulating the appetite, boosting qi and nourishing yin, antidiarrheal arresting seminal emission.Cure mainly diarrhea due to hypofunction of the spleen, asthenia chronic cough, the diseases such as seminal emission, leukorrhagia frequent micturition of quenching one's thirst.
Testis et penis callorhini: salty in the mouth, hot in nature, returns liver.Warming the kidney tonifying YANG, benefit essence mends marrow.Control deficient impairment caused by overstrain, sexual impotence essence declines, premature ejaculation, waist knee flaccidity, trusted subordinate's pain.One, tonifying YANG YIN nourishing, kidney-supplementing liver-boosting, endocrine regulation.Its whip is put down, and enters liver the kidney invigorating.Be applicable to because of diseases such as sexual impotence, premature ejaculation, sexual disorder and the insomnia and dreamful sleep caused by the groan kidney deficiency such as damage of kidney-YIN, insufficiency of kidney-YANG, dizzy forgetful, soreness of waist and knee, neurasthenia and immunologic hypofunctions; Two, blood yiqi.Hemoglobin in Testis et penis callorhini and hemoglobin high, be applicable to blood deficiency gas weak person; Three, skin care skin Caring.Containing a large amount of viscous protein in Testis et penis callorhini, there is slow down aging, keep the function of elasticity of skin and moisture; Four, bone and muscle strengthening.Testis et penis callorhini is the kidney invigorating treasure, and kidney by force then can bone and muscle strengthening." Bencao Jingshu ": " deficiency of YIN heated and hectic fever due to YIN-deficiency chronic cough wait, and saltyly avoided.”
Rhizoma Curcumae: pungent, bitter, temperature.Return liver, spleen channel.This product effect is similar to Rhizoma Sparganii, removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.But warm concerted effort is comparatively large, can treat amenorrhea due to stagnation of blood stomachache, abdominal mass, gather.Can the pain relieving of circulation of qi promoting removing food stagnancy, for eating accumulation, breast abdominal distention is vexed has a pain.Also can removing blood stasis, women's amenorrhea, or the lump in the abdomen addiction block of phlegm-damp congestion condensation.Aromatic turmeric oil preparation has the growth of the multiple tumor strains such as the L615 leukemia of Mouse Ehrlich Carcinoma Cells, 615 mouse inbred liness and ascites hepatoma cells in vitro and obviously suppresses and destruction.
Mylabris: acrid in the mouth, warm in nature, poison greatly.Enter large intestine, small intestinal, liver, kidney channel.Counteracting toxic substances phagedenoma, removing blood stasis eliminating stagnation.Amplification on Canon of Materia Medica: " pregnant body people can not take, and is people's meat of bursting.Antigonorrheic is multiplex, pole bitter man, and You Yi considers." counteracting toxic substances phagedenoma, removing blood stasis eliminating stagnation.Main carbuncle, scrofula, stubborn dermatitis, amenorrhea, lump in the abdomen, cancerous protuberance.Yong Yu WEIJIA lump, stubborn dermatitis for many years, scrofula, wart, carbuncle is not burst, the dead flesh of malignant boil.Treatment rheumatalgia, neuralgia etc. stick acupoint therapy extremities joint, the rheumatalgia (comprising occupational benign arthritis, myofibrositis, rheumatic arthritis, the arthralgia etc. that causes because of neurovascular disorders or wound) of lower back and neuralgia (the reflex neuro pain etc. in intercostal neuralgia, Trigeminal neuralgia, operation or trauma scar district), the convalescent pain in the hepatic region of infectious hepatitis etc. with Mylabris, all have certain short term effect.
Radix Et Rhizoma Nardostachyos: acrid in the mouth, sweet, warm in nature; Return spleen, stomach warp.Fragrance row is loose, warming spleen and stomach for dispelling cold, regulating QI to relieve pain, the effect of appetizing of being amusing.Compendium of Material Medica: " Radix Et Rhizoma Nardostachyos, it is strongly fragrant that fragrance can open spleen, adds in taste medicine less, gas of being very amusing "." Japan hanako materia medica ": " control abdominal distnetion, the therapeutic method to keep the adverse QI flowing downwards." to have fragrance row loose for Radix Et Rhizoma Nardostachyos, warming spleen and stomach for dispelling cold, regulating QI to relieve pain, the effect of appetizing of being amusing.Cure mainly coldness and pain in the epigastrium distension, anorexia, chest pain, toothache, tumbling down is grieved, beriberi edema, cramp caused by acute vomiting and diarrhea.Jatamansi volatile oil has faint antibacterial, wind dispelling and spasmolysis, to skin, mucosa without local irritation.Jatamansi is to rabbit hemostasis, and rabbit performance is to the bradykinesia, sleepy, the loss of appetite that stimulate.Radix Et Rhizoma Nardostachyos alcohol extract has blood pressure lowering and antiulcer action.
Poria: sweet, light is flat.GUIXIN warp, lung meridian, spleen channel, kidney channel.Function: diuretic, eliminating dampness by diuresis diuresis, spleen reinforcing, mind calming." medication heart method ": " sweet with supporing yang, the panacea of dehumidifying also for Poria, the sharp key of light energy.The flat YANG invigorating of sweet in the mouth, strengthening the spleen is relieved oedema or abdominal distension through diuresis or purgation, inducing QI of promoting the production of body fluid.”
The Rhizoma Anemarrhenae: bitter in the mouth, sweet, cold in nature, enters lung, stomach, kidney channel, has relieving restlessness of purging heat, the effect of nourshing Yin and drynsessmoistening prescription, clearing away lung-heat to relieve cough, and cure mainly fever caused by exogenous pathogenic factors, high heat is irritated, lung-heat type cough, and interior-heat such as to be quenched one's thirst at the symptom; Its bitter cold matter is moistened, and property sedimentation can heat clearing away, can promote the production of body fluid again, kindly controls warm pathogenic factor and enters edema caused by disorder of QI, intenseness of heat impairment of body fluid; Also diabetes is used for the treatment of; Phlegm-heat obstructing in the lung and breathing heavily, xeropulmonary cough, expectorant is few unfavorable; Hyperactivity of fire caused by deficiency of YIN, the symptoms such as hyperactivity of deficient fire.
Below adopt embodiment to describe embodiments of the present invention in detail, to the present invention, how application technology means solve technical problem whereby, and the implementation procedure reaching technique effect can fully understand and implement according to this.
Embodiment 1 pharmaceutical composition 1
Embodiments provide a kind of pharmaceutical composition for the treatment of milch cow hypogalactia, be made up of the raw medicinal material of following parts by weight: the Radix Astragali 20 weight portion, the Rhizoma Atractylodis Macrocephalae 32 weight portion, Rhizoma Gymnadeniae 15 weight portion, Radix seu Herba Gei aleppici 25 weight portion, Pericarpium Citri Reticulatae 28 weight portion, Radix Et Caulis Acanthopanacis Senticosi 25 weight portion, Ganoderma 30 weight portion, Herb Gynostemmae Pentaphylli 35 weight portion, Fructus cari carvi 23 weight portion, Fructus Jujubae 35 weight portion, Radix Pseudostellariae 33 weight portion, Radix hemerocalis plicatae 3 weight portion, Nux Prinsepiae 22 weight portion, Herba Limonii Gmelinii 30 weight portion, Rhizoma Dioscoreae 25 weight portion, Testis et penis callorhini 36 weight portion, Herba Canscorae 20 weight portion, Rhizoma panacis majoris 22 weight portion, Radix Aleuritis Fordii 3 weight portion, Rhizoma Curcumae 31 weight portion, Semen thlaspis 32 weight portion, Mylabris 20 weight portion, Herba Gonostegiae hirtae 36 weight portion and Cyananthus argernteus marg. 14 weight portion.
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 3 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 4 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 90%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 30 hours under the condition of 9 DEG C, adopt percolation with the speed of 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 50 minutes at this, the micron particles of acquisition 4 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets the mixed powder 15g that second step obtains, adds propylene glycol 40g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1.5g needle-use activated carbon, fully stirs 40 minutes; Decarbonization filtering; With 0.23 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
Embodiment 2 pharmaceutical composition 2
Embodiments provide a kind of pharmaceutical composition for the treatment of milch cow hypogalactia, be made up of the raw medicinal material of following parts by weight: the Radix Astragali 20 weight portion, the Rhizoma Atractylodis Macrocephalae 32 weight portion, Rhizoma Gymnadeniae 15 weight portion, Radix seu Herba Gei aleppici 25 weight portion, Pericarpium Citri Reticulatae 28 weight portion, Radix Et Caulis Acanthopanacis Senticosi 25 weight portion, Ganoderma 30 weight portion, Herb Gynostemmae Pentaphylli 35 weight portion, Fructus cari carvi 23 weight portion, Fructus Jujubae 35 weight portion, Radix Pseudostellariae 33 weight portion, Radix hemerocalis plicatae 3 weight portion, Nux Prinsepiae 22 weight portion, Herba Limonii Gmelinii 30 weight portion, Rhizoma Dioscoreae 25 weight portion, Testis et penis callorhini 36 weight portion, Herba Canscorae 20 weight portion, Rhizoma panacis majoris 22 weight portion, Radix Aleuritis Fordii 3 weight portion, Rhizoma Curcumae 31 weight portion, Semen thlaspis 32 weight portion, Mylabris 20 weight portion, Herba Gonostegiae hirtae 36 weight portion, Cyananthus argernteus marg. 14 weight portion, Radix Et Rhizoma Nardostachyos 20 weight portion, Poria cum Radix Pini 25 weight portion, Flos Loropetali (Herba Loropetali) 32 weight portion, Rhizoma Alismatis 21 weight portion, Poria 30 weight portion and the Rhizoma Anemarrhenae 22 weight portion.
The first step, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae and Herba Limonii Gmelinii are mixed in described ratio, with being the dissolve with ethanol of 90% relative to the determining alcohol of 4 times of mixture quality obtained, reflux was extracted after 3 hours, filter, obtain the first filtrate; By filtering residue again with the dissolve with ethanol of the determining alcohol 90% of 2 times relative to the mixture quality obtained, reflux was extracted after 2 hours, filtered, obtained the second filtrate; Merge the first filtrate and the second filtrate, decompression recycling ethanol to be concentrated into liquor strength be 0.8g crude drug/mL, through the macroporous adsorptive resins eluting that volume is 5L, first use deionized water or the distilled water eluting of 5 times of resin column volumes, be 90% ethanol elution with the determining alcohol of 3 times of resin column volumes again, collect ethanol elution, concentrating under reduced pressure removing ethanol, drying is also ground into powder;
Second step, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae and Cyananthus argernteus marg. are mixed in described ratio, add the ethanol of the determining alcohol 90% of 3 times relative to the mixture quality obtained, heating and refluxing extraction 2 times, extracting solution merges, with the centrifugal remove impurity of tube centrifuge, when the extracting solution after remove impurity being evaporated under the condition of 65 DEG C 60 DEG C, relative density is the mastic of 1.22, and the mastic spray dryer after concentrated is dried to powder;
3rd step, mixes surplus stock medical material in described ratio, adds the water dissolution of 3 times relative to the mixture quality obtained, and heating decoction 3 hours, filters; By filtering residue again with the water dissolution of 1.5 times relative to the mixture quality obtained, again heat decoction 1.5 hours, filter; Merge the filtrate of twice, concentrating under reduced pressure removing moisture, drying is also ground into powder;
4th step, the powder mixing first step, second step and the 3rd step obtained, is screened into 100 object fine powders subsequently, is dropped in mixing and blending machine by the fine powder of acquisition and stirs, namely obtain powder.
The toxicity test of pharmaceutical composition:
1, trial drug
Choose Radix Astragali 20g, Rhizoma Atractylodis Macrocephalae 32g, Rhizoma Gymnadeniae 15g, Radix seu Herba Gei aleppici 25g, Pericarpium Citri Reticulatae 28g, Radix Et Caulis Acanthopanacis Senticosi 25g, Ganoderma 30g, Herb Gynostemmae Pentaphylli 35g, Fructus cari carvi 23g, Fructus Jujubae 35g, Radix Pseudostellariae 33g, Radix hemerocalis plicatae 3g, Nux Prinsepiae 22g, Herba Limonii Gmelinii 30g, Rhizoma Dioscoreae 25g, Testis et penis callorhini 36g, Herba Canscorae 20g, Rhizoma panacis majoris 22g, Radix Aleuritis Fordii 3g, Rhizoma Curcumae 31g, Semen thlaspis 32g, Mylabris 20g, Herba Gonostegiae hirtae 36g and Cyananthus argernteus marg. 14g to mix, be ground into powder; Added by acquisition powder in 1400g cold water and soak 25 hours, with slow fire boiling, decocting time is 1.5 hours, decoction liquor is filtered, obtains the first filtrate, collects filtering residue; Again add in 1400g cold water by filtering the filtering residue obtained, with slow fire boiling 3 times, each decoction 1 hour, filters and merges filtrate, obtaining the second filtrate; Merge twice filtrate, concentrating under reduced pressure remove portion water, obtain decoction, the crude drug concentration of decoction is 3g/ml.
2, test method: select SD rat, give the decoction of the Chinese medicine additive of the present invention of variable concentrations (18.0,6.0,2.0g crude drug/kg), every day gavage once, continuous 90 days, within after last administration 24 hours, respectively group is alive kills 1/2 animal (male and female half and half), and all the other 1/2 animals continue observations 2 weeks rear living and kill.Duration of test observes outward appearance, general behavior, food ration, the body weight change of animal, within after administration 90 days, within 2 weeks, carries out the index checking such as hematology's (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemical (AST, ALT, ALP, Glu, BUN, Crca, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology with drug withdrawal.Result of the test shows: Chinese medicine additive of the present invention is good at high, medium and low dosage treated animal general state, and outward appearance sign, behavioral activity, food-intake and body weight increase change all without exception; Three dosage groups and matched group hematological examination, blood biochemical analysis, urine biochemical analysis all in normal range, without significant difference between group; Each group of main organs histopathological examination shows no obvious abnormalities.These parameters drug withdrawal also had no change after 2 weeks.This test dosage is respectively 180,60,20 times of clinical medicine dose, rat is had no significant effect in high, medium and low three dosage (18.0,6.0,2.0g crude drug/kg) administration in continuous 90 days according to result of the test Chinese medicine preparation of the present invention, without clear and definite toxicity target organ and sensitive indicator, convalescent period observation also has no retardance toxic reaction, points out the dose safety of Chinese medicine preparation clinical practice of the present invention higher.
Contrast test
Miao Fu plant of Heshun County of Shanxi Province, in by the end of December, 2012, find the milch cow of 300 1.5 years old mean aves nearly, occur that breast is in various degree tightly little in first lactation period, nipple cripetura, outward appearance is inmature, agalactosis, refusal suckling, the thin deficiency of vital energy of body, or run into hot summer high temperature season milch cow appetite and die-off or do not eat.
From above-mentioned 300 cow heads, choose 180,180 cow heads are divided into three groups at random, be respectively embodiment group 1, embodiment group 2 and matched group, the ill milch cow of three groups all without significant difference, has comparability in body weight, the state of an illness etc.Embodiment group 1, embodiment group 2 and matched group use the powder of the injectable powder of the embodiment of the present invention 1, embodiment 2 and conventional medicament to treat respectively; Wherein, injectable powder adopts subcutaneous injection, each 60mg/kg, twice daily, and injection 6 days continuously; The using method of powder be by powder according in the part by weight conventional feed of 7g:480g, feed continuously 6 days; Conventional medicament is venae subcutaneae injection pituitrin 50 unit, continuous 6 days, conventional feed of feeding.Experimental period is 6 days, each group of ill milch cow body weight is taken respectively before and after experiment, period records recovery from illness situation and the death toll of ill milch cow, calculate cure rate, the average lactation amount of every cow head, average daily ingestion amount and average body condition divide (BCS), and cure time of number and compare, result is as shown in table 1, table 2 and table 3.Wherein, cure: normally, milk is full, and no longer include the phenomenon that appetite die-offs or do not eat, breast is full for breast and nipple, and nipple recovers normal; Invalid: clinical symptoms is not improved.
The therapeutic effect synopsis of each experimental group milch cow of table 1
Data from table 1: compared with conventional medicament, the medicine of the embodiment of the present invention 1 and 2 has advantage that is evident in efficacy, cheap, that have no side effect in treatment milch cow hypogalactia.
Known by contrast test: compared with conventional medicament, the pharmaceutical composition of the embodiment of the present invention 1 and 2 has toxic and side effects advantage little, evident in efficacy in treatment milch cow hypogalactia, but also can be good at the normal growth ensureing cow mammary gland and other organs of health thereof.
In each experimental group of table 2, the average lactation amount of every cow head, average daily ingestion amount and average body condition divide the therapeutic effect synopsis of (BCS)
| Group | Average lactation amount (kg/d) | Average daily ingestion amount (kg/d) | Average body condition divides (BCS) |
| Embodiment group 1 | 22.7±5.43 | 28.2±0.4 | 2.7±0.25 |
| Embodiment group 2 | 25.3±5.43 | 31.9±0.4 | 3.0±0.25 |
| Matched group | 18.9±5.43 | 25.9±0.4 | 1.5±0.25 |
Data from table 2: average lactation amount and the average daily ingestion amount of embodiment group 1 and embodiment group 2 all have growth than matched group, improve 3.8kg/d, 6.4kg/d and 2.3kg/d, 6kg/d respectively.The average body condition of embodiment group 1 and embodiment group 2 divides (BCS) to make moderate progress relative to matched group.
Known by contrast test: compared with conventional medicament, the pharmaceutical composition of the embodiment of the present invention 1 and 2 is in treatment milch cow hypogalactia, there is high, the average daily ingestion amount of average lactation amount also increase, average body condition divides (BCS) also relatively to make moderate progress, breast is full and nipple is normal, milk is full, no longer includes the phenomenon that appetite die-offs or do not eat.
The time comparative example (%) of number of fully recovering afterwards for 6 days treated respectively by table 3 respectively group
| Group | Number of cases | 1-2 days | 3-4 days | 5-6 days |
| Embodiment group 1 | 60 | （56）93.3% | （4）6.7% | （0）0% |
| Embodiment 2 | 60 | （58）96.7% | （2）3.3% | （0）0% |
| Matched group | 43 | （1）2.3% | （3）7% | （39）90.7% |
Data from table 3: pharmaceutical composition of the present invention, to treatment milch cow hypogalactia, relative to conventional medicament on therapeutic effect, has significant improvement, obviously shortens and treat the course for the treatment of.
Model case:
In January, 2014 Shanxi Hua Xin plant the milch cow of 450 1.5 years old mean aves, nearly in first lactation period, 160 milch cows occur that breast is in various degree tightly little, nipple cripetura, outward appearance is inmature, agalactosis, refusal suckling, the thin deficiency of vital energy of body, or run into hot summer high temperature season milch cow appetite and die-off or the symptom such as not eat.Choose 50 ill milch cows wherein, start to feed and be added with the feedstuff of the embodiment of the present invention 2 powder, powder is mixed in conventional feed according to 7g:480g weight ratio, feed 6 days, within 2nd day, ill milch cow symptom is obviously improved, within 3rd day, 50 milch cows are all fully recovered, after continuing to feed 4 days, compared with healthy cow, breast and nipple normal, milk is full, and no longer include the phenomenon that appetite die-offs or do not eat, breast is full, nipple recovers normal, compared with healthy cow, average lactation amount height and average daily ingestion amount increase, and average body condition divides (BCS) also relatively to make moderate progress.
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. treat the pharmaceutical composition of milch cow hypogalactia for one kind, it is characterized in that, described pharmaceutical composition comprises following raw medicinal material: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Gymnadeniae, Radix seu Herba Gei aleppici, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae, Herba Limonii Gmelinii, Rhizoma Dioscoreae, Testis et penis callorhini, Herba Canscorae, Rhizoma panacis majoris, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae and Cyananthus argernteus marg..
2. the pharmaceutical composition for the treatment of milch cow hypogalactia according to claim 1, it is characterized in that, in described pharmaceutical composition, the ratio of weight and number of each raw medicinal material is: Radix Astragali 10-25 weight portion, Rhizoma Atractylodis Macrocephalae 12-35 weight portion, Rhizoma Gymnadeniae 10-22 weight portion, Radix seu Herba Gei aleppici 13-27 weight portion, Pericarpium Citri Reticulatae 10-30 weight portion, Radix Et Caulis Acanthopanacis Senticosi 10-32 weight portion, Ganoderma 15-35 weight portion, Herb Gynostemmae Pentaphylli 14-36 weight portion, Fructus cari carvi 13-31 weight portion, Fructus Jujubae 10-35 weight portion, Radix Pseudostellariae 13-34 weight portion, Radix hemerocalis plicatae 3-5 weight portion, Nux Prinsepiae 12-22 weight portion, Herba Limonii Gmelinii 13-33 weight portion, Rhizoma Dioscoreae 12-32 weight portion, Testis et penis callorhini 12-36 weight portion, Herba Canscorae 10-21 weight portion, Rhizoma panacis majoris 12-25 weight portion, Radix Aleuritis Fordii 3-5 weight portion, Rhizoma Curcumae 11-31 weight portion, Semen thlaspis 13-32 weight portion, Mylabris 10-30 weight portion, Herba Gonostegiae hirtae 13-36 weight portion and Cyananthus argernteus marg. 14-24 weight portion.
3. the pharmaceutical composition for the treatment of milch cow hypogalactia according to claim 1 and 2, it is characterized in that, in described pharmaceutical composition, the ratio of weight and number of each raw medicinal material is: the Radix Astragali 20 weight portion, the Rhizoma Atractylodis Macrocephalae 32 weight portion, Rhizoma Gymnadeniae 15 weight portion, Radix seu Herba Gei aleppici 25 weight portion, Pericarpium Citri Reticulatae 28 weight portion, Radix Et Caulis Acanthopanacis Senticosi 25 weight portion, Ganoderma 30 weight portion, Herb Gynostemmae Pentaphylli 35 weight portion, Fructus cari carvi 23 weight portion, Fructus Jujubae 35 weight portion, Radix Pseudostellariae 33 weight portion, Radix hemerocalis plicatae 3 weight portion, Nux Prinsepiae 22 weight portion, Herba Limonii Gmelinii 30 weight portion, Rhizoma Dioscoreae 25 weight portion, Testis et penis callorhini 36 weight portion, Herba Canscorae 20 weight portion, Rhizoma panacis majoris 22 weight portion, Radix Aleuritis Fordii 3 weight portion, Rhizoma Curcumae 31 weight portion, Semen thlaspis 32 weight portion, Mylabris 20 weight portion, Herba Gonostegiae hirtae 36 weight portion and Cyananthus argernteus marg. 14 weight portion.
4. the pharmaceutical composition of the treatment milch cow hypogalactia according to any one of claim 1-3, it is characterized in that, described pharmaceutical composition also comprises Radix Et Rhizoma Nardostachyos, Poria cum Radix Pini, Flos Loropetali (Herba Loropetali), Rhizoma Alismatis, Poria and the Rhizoma Anemarrhenae.
5. the pharmaceutical composition of the treatment milch cow hypogalactia according to any one of claim 1-4, is characterized in that, in described pharmaceutical composition, the parts by weight of each raw medicinal material are: Radix Astragali 10-25 weight portion, Rhizoma Atractylodis Macrocephalae 12-35 weight portion, Rhizoma Gymnadeniae 10-22 weight portion, Radix seu Herba Gei aleppici 13-27 weight portion, Pericarpium Citri Reticulatae 10-30 weight portion, Radix Et Caulis Acanthopanacis Senticosi 10-32 weight portion, Ganoderma 15-35 weight portion, Herb Gynostemmae Pentaphylli 14-36 weight portion, Fructus cari carvi 13-31 weight portion, Fructus Jujubae 10-35 weight portion, Radix Pseudostellariae 13-34 weight portion, Radix hemerocalis plicatae 3-5 weight portion, Nux Prinsepiae 12-22 weight portion, Herba Limonii Gmelinii 13-33 weight portion, Rhizoma Dioscoreae 12-32 weight portion, Testis et penis callorhini 12-36 weight portion, Herba Canscorae 10-21 weight portion, Rhizoma panacis majoris 12-25 weight portion, Radix Aleuritis Fordii 3-5 weight portion, Rhizoma Curcumae 11-31 weight portion, Semen thlaspis 13-32 weight portion, Mylabris 10-30 weight portion, Herba Gonostegiae hirtae 13-36 weight portion, Cyananthus argernteus marg. 14-24 weight portion, Radix Et Rhizoma Nardostachyos 10-20 weight portion, Poria cum Radix Pini 10-30 weight portion, Flos Loropetali (Herba Loropetali) 12-32 weight portion, Rhizoma Alismatis 11-21 weight portion, Poria 12-32 weight portion and Rhizoma Anemarrhenae 14-24 weight portion.
6. the pharmaceutical composition of the treatment milch cow hypogalactia according to any one of claim 1-5, it is characterized in that, in described pharmaceutical composition, the parts by weight of each raw medicinal material are: the Radix Astragali 20 weight portion, the Rhizoma Atractylodis Macrocephalae 32 weight portion, Rhizoma Gymnadeniae 15 weight portion, Radix seu Herba Gei aleppici 25 weight portion, Pericarpium Citri Reticulatae 28 weight portion, Radix Et Caulis Acanthopanacis Senticosi 25 weight portion, Ganoderma 30 weight portion, Herb Gynostemmae Pentaphylli 35 weight portion, Fructus cari carvi 23 weight portion, Fructus Jujubae 35 weight portion, Radix Pseudostellariae 33 weight portion, Radix hemerocalis plicatae 3 weight portion, Nux Prinsepiae 22 weight portion, Herba Limonii Gmelinii 30 weight portion, Rhizoma Dioscoreae 25 weight portion, Testis et penis callorhini 36 weight portion, Herba Canscorae 20 weight portion, Rhizoma panacis majoris 22 weight portion, Radix Aleuritis Fordii 3 weight portion, Rhizoma Curcumae 31 weight portion, Semen thlaspis 32 weight portion, Mylabris 20 weight portion, Herba Gonostegiae hirtae 36 weight portion, Cyananthus argernteus marg. 14 weight portion, Radix Et Rhizoma Nardostachyos 20 weight portion, Poria cum Radix Pini 25 weight portion, Flos Loropetali (Herba Loropetali) 32 weight portion, Rhizoma Alismatis 21 weight portion, Poria 30 weight portion and the Rhizoma Anemarrhenae 22 weight portion.
7. the pharmaceutical composition of the treatment milch cow hypogalactia according to any one of claim 1-6, is characterized in that, the dosage form of described pharmaceutical composition is injectable powder, and its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
8. the pharmaceutical composition of the treatment milch cow hypogalactia according to any one of claim 1-6, is characterized in that, the dosage form of described pharmaceutical composition is powder, and its preparation method comprises the following steps:
The first step, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae and Herba Limonii Gmelinii are mixed in described ratio, with being the dissolve with ethanol of 85% ~ 95% relative to the determining alcohol of 3 ~ 5 times of mixture quality obtained, reflux was extracted after 2 ~ 4 hours, filter, obtain the first filtrate; By filtering residue again with the dissolve with ethanol of the determining alcohol 85% ~ 95% of 1 ~ 2 times relative to the mixture quality obtained, reflux was extracted after 1 ~ 2 hour, filtered, obtained the second filtrate; Merge the first filtrate and the second filtrate, decompression recycling ethanol to be concentrated into liquor strength be 0.7 ~ 0.9g crude drug/mL, through the macroporous adsorptive resins eluting that volume is 5L, first use deionized water or the distilled water eluting of 5 times of resin column volumes, be 90% ~ 95% ethanol elution with the determining alcohol of 3 times of resin column volumes again, collect ethanol elution, concentrating under reduced pressure removing ethanol, drying is also ground into powder;
Second step, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae and Cyananthus argernteus marg. are mixed in described ratio, add the ethanol of the determining alcohol 85% ~ 95% of 2 ~ 4 times relative to the mixture quality obtained, heating and refluxing extraction 1 ~ 2 time, extracting solution merges, with the centrifugal remove impurity of tube centrifuge, when the extracting solution after remove impurity being evaporated under the condition of 60 DEG C ~ 70 DEG C 60 DEG C, relative density is the mastic of 1.20 ~ 1.23, and the mastic spray dryer after concentrated is dried to powder;
3rd step, mixes surplus stock medical material in described ratio, adds the water dissolution of 2 ~ 4 times relative to the mixture quality obtained, and heating decoction 2 ~ 4 hours, filters; By filtering residue again with the water dissolution of 1 ~ 2 times relative to the mixture quality obtained, again heat decoction 1 ~ 2 hour, filter; Merge the filtrate of twice, concentrating under reduced pressure removing moisture, drying is also ground into powder;
4th step, the powder mixing first step, second step and the 3rd step obtained, is screened into 80 ~ 120 object fine powders subsequently, is dropped in mixing and blending machine by the fine powder of acquisition and stirs, namely obtain powder.
9. a preparation method for the pharmaceutical composition of the treatment milch cow hypogalactia as described in any one of claim 1-6, is characterized in that, the dosage form of described pharmaceutical composition is injectable powder, and its preparation method comprises the following steps:
The first step, described raw medicinal material is mixed in proportion, put into super micron mill and be ground into the mixed powder that the micron particles of 0.1 ~ 10 μm of volume average particle size and particle diameter be less than the nano-scale particle composition of 0.1 μm of volume average particle size, described mixed powder powder rate be at least 95%;
Second step, adding relative to the determining alcohol of the quality 3 ~ 5 times of described mixed powder in the mixed powder that the first step obtains is the ethanol of 85% ~ 95%, stirring and dissolving obtains alcoholic solution, alcoholic solution is left standstill 24 ~ 36 hours under the condition of 5 DEG C ~ 10 DEG C, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation, collect percolate, concentrated and dry, and put into super micron mill pulverizing 40 ~ 60 minutes at this, the micron particles of acquisition 0.1 ~ 10 μm of volume average particle size and particle diameter are less than the mixed powder of the nano-scale particle composition of 0.1 μm of volume average particle size, the powder rate that obtains of described mixed powder is at least 95%,
3rd step, gets mixed powder 10g ~ 20g that second step obtains, adds propylene glycol 30g ~ 50g, add 200ml water for injection, stirs and makes it dissolve, inject water to 1000ml further, then add 1g ~ 1.5g needle-use activated carbon, fully stir 30 ~ 50 minutes; Decarbonization filtering; With 0.22 ~ 0.24 μm of filtering with microporous membrane; Lyophilization obtains sterilized powder, subpackage embedding.
10. a preparation method for the pharmaceutical composition of the treatment milch cow hypogalactia as described in any one of claim 1-6, is characterized in that, the dosage form of described pharmaceutical composition is powder, and its preparation method comprises the following steps:
The first step, Pericarpium Citri Reticulatae, Radix Et Caulis Acanthopanacis Senticosi, Ganoderma, Herb Gynostemmae Pentaphylli, Fructus cari carvi, Fructus Jujubae, Radix Pseudostellariae, Radix hemerocalis plicatae, Nux Prinsepiae and Herba Limonii Gmelinii are mixed in described ratio, with being the dissolve with ethanol of 85% ~ 95% relative to the determining alcohol of 3 ~ 5 times of mixture quality obtained, reflux was extracted after 2 ~ 4 hours, filter, obtain the first filtrate; By filtering residue again with the dissolve with ethanol of the determining alcohol 85% ~ 95% of 1 ~ 2 times relative to the mixture quality obtained, reflux was extracted after 1 ~ 2 hour, filtered, obtained the second filtrate; Merge the first filtrate and the second filtrate, decompression recycling ethanol to be concentrated into liquor strength be 0.7 ~ 0.9g crude drug/mL, through the macroporous adsorptive resins eluting that volume is 5L, first use deionized water or the distilled water eluting of 5 times of resin column volumes, be 90% ~ 95% ethanol elution with the determining alcohol of 3 times of resin column volumes again, collect ethanol elution, concentrating under reduced pressure removing ethanol, drying is also ground into powder;
Second step, Radix Aleuritis Fordii, Rhizoma Curcumae, Semen thlaspis, Mylabris, Herba Gonostegiae hirtae and Cyananthus argernteus marg. are mixed in described ratio, add the ethanol of the determining alcohol 85% ~ 95% of 2 ~ 4 times relative to the mixture quality obtained, heating and refluxing extraction 1 ~ 2 time, extracting solution merges, with the centrifugal remove impurity of tube centrifuge, when the extracting solution after remove impurity being evaporated under the condition of 60 DEG C ~ 70 DEG C 60 DEG C, relative density is the mastic of 1.20 ~ 1.23, and the mastic spray dryer after concentrated is dried to powder;
3rd step, mixes surplus stock medical material in described ratio, adds the water dissolution of 2 ~ 4 times relative to the mixture quality obtained, and heating decoction 2 ~ 4 hours, filters; By filtering residue again with the water dissolution of 1 ~ 2 times relative to the mixture quality obtained, again heat decoction 1 ~ 2 hour, filter; Merge the filtrate of twice, concentrating under reduced pressure removing moisture, drying is also ground into powder;
4th step, the powder mixing first step, second step and the 3rd step obtained, is screened into 80 ~ 120 object fine powders subsequently, is dropped in mixing and blending machine by the fine powder of acquisition and stirs, namely obtain powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510616083.1A CN105056160A (en) | 2015-09-25 | 2015-09-25 | Medicine composition for treating agalactia of cows and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510616083.1A CN105056160A (en) | 2015-09-25 | 2015-09-25 | Medicine composition for treating agalactia of cows and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105056160A true CN105056160A (en) | 2015-11-18 |
Family
ID=54485829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510616083.1A Pending CN105056160A (en) | 2015-09-25 | 2015-09-25 | Medicine composition for treating agalactia of cows and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105056160A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853984A (en) * | 2016-06-02 | 2016-08-17 | 烟台民望机电技术有限公司 | Pharmaceutical composition for treating hypogalactia of dairy cows and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101143177A (en) * | 2007-08-16 | 2008-03-19 | 河南花花牛奶牛育种科技有限公司 | Medicine for preventing and treating postpartum disease of cow |
| CN101385797A (en) * | 2008-08-29 | 2009-03-18 | 布焕景 | Medicine for treating cow hypogalactia after delivery |
| CN101554400A (en) * | 2008-04-09 | 2009-10-14 | 北京大北农动物保健科技有限责任公司 | Medicine for preventing and curing agalactia, lactation lack and mastitis of livestock and preparation method thereof |
| CN104398991A (en) * | 2014-12-02 | 2015-03-11 | 山东新希望六和集团有限公司 | Medicinal composition for treating hypogalactia symptom of dairy cow and preparation method thereof |
-
2015
- 2015-09-25 CN CN201510616083.1A patent/CN105056160A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101143177A (en) * | 2007-08-16 | 2008-03-19 | 河南花花牛奶牛育种科技有限公司 | Medicine for preventing and treating postpartum disease of cow |
| CN101554400A (en) * | 2008-04-09 | 2009-10-14 | 北京大北农动物保健科技有限责任公司 | Medicine for preventing and curing agalactia, lactation lack and mastitis of livestock and preparation method thereof |
| CN101385797A (en) * | 2008-08-29 | 2009-03-18 | 布焕景 | Medicine for treating cow hypogalactia after delivery |
| CN104398991A (en) * | 2014-12-02 | 2015-03-11 | 山东新希望六和集团有限公司 | Medicinal composition for treating hypogalactia symptom of dairy cow and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 瞿自明: "《新编中兽医治疗大全》", 31 December 1993 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853984A (en) * | 2016-06-02 | 2016-08-17 | 烟台民望机电技术有限公司 | Pharmaceutical composition for treating hypogalactia of dairy cows and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078520B (en) | Chinese medicinal preparation for treating nervous headache and preparation method thereof | |
| CN102048933A (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN104367879A (en) | Pharmaceutical composition for chickens' internal lesion caused by overexertion and preparation method of pharmaceutical composition | |
| CN104799003A (en) | Compound feed for 10-30-day-old piglets and preparing method thereof | |
| CN105076894A (en) | Cow mixed feed and preparation method thereof | |
| CN104840695A (en) | Medicine combination for treating white scour of piglet and preparation method thereof | |
| CN104398991A (en) | Medicinal composition for treating hypogalactia symptom of dairy cow and preparation method thereof | |
| CN104905267A (en) | Semen cassiae health oral liquid capable of decreasing blood lipid and preparation method thereof | |
| CN103432412B (en) | Medicament for treating hyperplasia of mammary glands and preparation method thereof | |
| CN103749819B (en) | Fructus Corni health protection tea of a kind of hypoglycemic and preparation method thereof | |
| CN102846824B (en) | Traditional Chinese medicinal composition for treating cold dampness blood stasis blocking channel type diabetic feet, and its preparation method | |
| CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
| CN103933538A (en) | Medicine for treating spleen-kidney yang deficiency type cirrhosis ascites and preparation method thereof | |
| CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
| CN104815265A (en) | Pharmaceutical composition for treating cow pulmonary edema and preparation method thereof | |
| CN103656048A (en) | Drug for treating cow mastitis and preparation method thereof | |
| CN104162093A (en) | Traditional Chinese medicinal preparation for treating breast cancer, and preparation method thereof | |
| CN103099885A (en) | Soft capsules having acne removing function and preparation method thereof | |
| CN105056160A (en) | Medicine composition for treating agalactia of cows and preparation method thereof | |
| CN104906502A (en) | Pharmaceutical composition for treatment of chicken damaged by heat and preparation method thereof | |
| CN104223062B (en) | Root bark of Chinese wolf-berry health care oral liquid of a kind of reducing pressure and sugar and preparation method thereof | |
| CN103356870A (en) | Traditional Chinese medicinal preparation for treating postpartum hypogalactia, and preparation method thereof | |
| CN105012847A (en) | Traditional Chinese medicine for preventing miscarriages and reinforcing uteri | |
| CN105412730A (en) | Medicine for treating piglet edema disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151118 |